• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于掩蔽和重定向治疗性病毒的 HPMA 共聚物。

HPMA copolymers for masking and retargeting of therapeutic viruses.

机构信息

University of Oxford, Department of Clinical Pharmacology, Old Road Campus Research Building, Old Road Campus, off Roosevelt Drive, Headington, Oxford OX3 7DQ United Kingdom.

出版信息

Adv Drug Deliv Rev. 2010 Feb 17;62(2):240-5. doi: 10.1016/j.addr.2009.12.003. Epub 2009 Dec 29.

DOI:10.1016/j.addr.2009.12.003
PMID:20005911
Abstract

Hydrophilic polymers are widely used already for steric stabilisation of bioactive proteins, changing their pharmacokinetics and modifying their interactions with the biological environment. Polymers may also be conjugated to biological surfaces, such as viruses, bacteria and mammalian cells, also to endow steric protection and changed properties. Reactive polymers based on N-[2-hydroxypropyl]methacrylamide have shown particular promise for surface coating of viruses, particularly adenovirus, and here we describe the important observations and innovations arising from this combination of chemical and genetic engineering. Adenovirus is a versatile agent that already finds important experimental applications as a recombinant vaccine, and also for cancer therapy, although its activity in both settings is often limited by a potent antibody-neutralising response in humans that is generally not seen in experimental animals. Coating with HPMA copolymers provides protection against neutralisation by antibodies and complement, and covalent linkage of novel ligands to the surface of the polymer can endow new infectious tropisms, mediated through different receptors, that can expand the potential applications of this versatile technology for a range of settings.

摘要

亲水性聚合物已广泛用于生物活性蛋白质的空间稳定化,改变其药代动力学并修饰其与生物环境的相互作用。聚合物也可以与生物表面(如病毒、细菌和哺乳动物细胞)结合,从而提供空间保护和改变性质。基于 N-[2-羟丙基]甲基丙烯酰胺的反应性聚合物在病毒,特别是腺病毒的表面涂层方面显示出特殊的前景,在这里我们描述了这种化学和遗传工程组合带来的重要观察结果和创新。腺病毒是一种多功能制剂,已经作为重组疫苗在实验中找到了重要的应用,也用于癌症治疗,尽管其在这两种情况下的活性通常都受到人类中强大的抗体中和反应的限制,而在实验动物中通常不会出现这种反应。用 HPMA 共聚物进行涂层可防止抗体和补体的中和,并且通过不同的受体,将新型配体共价连接到聚合物表面可以赋予新的感染嗜性,从而可以扩展这种多功能技术在一系列环境中的潜在应用。

相似文献

1
HPMA copolymers for masking and retargeting of therapeutic viruses.用于掩蔽和重定向治疗性病毒的 HPMA 共聚物。
Adv Drug Deliv Rev. 2010 Feb 17;62(2):240-5. doi: 10.1016/j.addr.2009.12.003. Epub 2009 Dec 29.
2
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.聚合物包被的腺病毒可实现高效的靶向重定向并规避中和抗体。
Gene Ther. 2001 Mar;8(5):341-8. doi: 10.1038/sj.gt.3301389.
3
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.将聚合物包被的腺病毒重新靶向至成纤维细胞生长因子受体可实现有效感染,并在人卵巢癌腹膜模型中介导疗效。
J Gene Med. 2008 Mar;10(3):280-9. doi: 10.1002/jgm.1121.
4
Polyvalent Diazonium Polymers Provide Efficient Protection of Oncolytic Adenovirus Enadenotucirev from Neutralizing Antibodies while Maintaining Biological Activity In Vitro and In Vivo.多价重氮聚合物在保持体外和体内生物学活性的同时,为溶瘤腺病毒 Enadenotucirev 提供有效的中和抗体保护。
Bioconjug Chem. 2019 Apr 17;30(4):1244-1257. doi: 10.1021/acs.bioconjchem.9b00189. Epub 2019 Mar 27.
5
Coating of adeno-associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera.用反应性聚合物包裹腺相关病毒可以消除病毒嗜性、实现重新靶向并提供对中和抗血清的抗性。
J Gene Med. 2008 Apr;10(4):400-11. doi: 10.1002/jgm.1161.
6
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.用靶向表皮生长因子受体的聚合物包裹腺病毒对卵巢癌进行病毒疗法。
Mol Ther. 2008 Feb;16(2):244-51. doi: 10.1038/sj.mt.6300363. Epub 2007 Dec 11.
7
Structural and chemical aspects of HPMA copolymers as drug carriers.作为药物载体的 HPMA 共聚物的结构和化学方面。
Adv Drug Deliv Rev. 2010 Feb 17;62(2):150-66. doi: 10.1016/j.addr.2009.10.007. Epub 2009 Nov 18.
8
Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.用于克服多药耐药性的肿瘤靶向胶束形成嵌段共聚物。
J Control Release. 2017 Jan 10;245:41-51. doi: 10.1016/j.jconrel.2016.11.020. Epub 2016 Nov 18.
9
N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.N-(2-羟丙基)甲基丙烯酰胺共聚物-6-(3-氨丙基)-玫瑰树碱缀合物。合成、体外及初步体内评估。
Bioconjug Chem. 2001 Sep-Oct;12(5):711-8. doi: 10.1021/bc0001544.
10
Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations.利用 HPMA 共聚物纳米药物制剂提高联合抗癌疗法的疗效。
Adv Drug Deliv Rev. 2010 Feb 17;62(2):203-30. doi: 10.1016/j.addr.2009.11.028. Epub 2009 Dec 4.

引用本文的文献

1
Hydrophilic biomaterials: From crosslinked and self-assembled hydrogels to polymer-drug conjugates and drug-free macromolecular therapeutics.亲水性生物材料:从交联和自组装水凝胶到聚合物药物偶联物和无药物的高分子治疗剂。
J Control Release. 2024 Sep;373:1-22. doi: 10.1016/j.jconrel.2024.05.012. Epub 2024 May 17.
2
Polymer nanomedicines.聚合物纳米药物。
Adv Drug Deliv Rev. 2020;156:40-64. doi: 10.1016/j.addr.2020.07.020. Epub 2020 Jul 28.
3
Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas.
犬脂肪间充质干细胞(cAdMSCs)作为痘苗病毒介导的溶瘤治疗犬软组织肉瘤的“特洛伊木马”。
Viruses. 2020 Jul 12;12(7):750. doi: 10.3390/v12070750.
4
High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy.高容量腺相关病毒载体:拓展基因治疗的范围。
Int J Mol Sci. 2020 May 21;21(10):3643. doi: 10.3390/ijms21103643.
5
Oligopeptide-modified poly(beta-amino ester)s-coated AdNuPARmE1A: Boosting the efficacy of intravenously administered therapeutic adenoviruses.寡肽修饰的聚(β-氨基酯)包裹的 AdNuPARmE1A:提高静脉给药治疗性腺病毒的疗效。
Theranostics. 2020 Feb 3;10(6):2744-2758. doi: 10.7150/thno.40902. eCollection 2020.
6
Molecular Mechanisms of the Interactions of -(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins.用于癌症治疗的聚(2-羟丙基)甲基丙烯酰胺共聚物与血浆蛋白相互作用的分子机制
Pharmaceutics. 2020 Jan 28;12(2):106. doi: 10.3390/pharmaceutics12020106.
7
Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral Vectors.超越基因递送:工程化病毒载体表面的策略。
Biomedicines. 2013 Dec 4;1(1):3-16. doi: 10.3390/biomedicines1010003.
8
Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.关于用于局部和全身基因治疗的纳米材料包被病毒载体的不断发展的经验教训。
Nanomedicine (Lond). 2016 Jul;11(13):1689-713. doi: 10.2217/nnm-2016-0060. Epub 2016 Jun 27.
9
Oncolytic virotherapy for urological cancers.溶瘤病毒治疗泌尿系统癌症。
Nat Rev Urol. 2016 Jun;13(6):334-52. doi: 10.1038/nrurol.2016.84. Epub 2016 May 24.
10
pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.靶向酸性肿瘤微环境和血管生成的pH敏感型溶瘤腺病毒杂交体
J Control Release. 2015 May 10;205:134-43. doi: 10.1016/j.jconrel.2015.01.005. Epub 2015 Jan 7.